Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20151109024975N11
IRCT20151109024975N11
Completed
Phase 3

Study of the effect of intra-arterial administration of nitroglycerin and labetalol on radial artery diameter and spasm in patients undergoing radial angiography

Sari University of Medical Sciences0 sites64 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRadial angiography-induced spasm.

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Radial angiography-induced spasm.
Sponsor
Sari University of Medical Sciences
Enrollment
64
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sari University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •All patients over 18 years old are candidates for radial angiography

Exclusion Criteria

  • •History of using radial artery during previous procedures
  • •Peripheral vascular diseases
  • •Raynaud syndrome
  • •Ejection fraction \<40%
  • •Heart rate at rest less than 55
  • •Systolic blood pressure less than 90 mmHg
  • •History of liver disease
  • •History of labetalol or nitroglycerin allergy
  • •Dissatisfaction patient to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Hemodynamic consequences of intra arterial treatment of intracranial aneurysms using non-invasive quantitative flow measurements from arterial spin labeling techniques in high field strength MRI.Aneurysmvascular distension10002363
NL-OMON37854niversitair Medisch Centrum Groningen20
Not yet recruiting
Phase 4
To assess the effect of the drug tranexamic acid on the blood loss and rate of blood transfusion by infiltrating it into the joint and by giving it directly into the vein in patients undergoing total knee replacement surgery.Health Condition 1: M171- Unilateral primary osteoarthritisof knee
CTRI/2019/01/017105Ganga Hospital
Active, not recruiting
Phase 1
A clinical trial to test the efficacy and safety of a bone marrow cell preparation to treat Critical Limb Ischemia in Subjects with Diabetes Mellitus.
EUCTR2016-000240-34-ATRexgenero Limited60
Active, not recruiting
Phase 1
A clinical trial to test the efficacy and safety of a bone marrow cell preparation to treat Critical Limb Ischemia in Subjects with Diabetes Mellitus.Critical Limb Ischemia in patients with Diabetes MellitusMedDRA version: 21.1Level: LLTClassification code 10077142Term: Limb ischemiaSystem Organ Class: 100000004866MedDRA version: 21.1Level: LLTClassification code 10058069Term: Critical limb ischemiaSystem Organ Class: 100000004866MedDRA version: 20.0Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2016-000240-34-PLRexgenero Limited60
Active, not recruiting
Phase 1
A clinical trial to test the efficacy and safety of intra-arterial administration of REX-001 to treat ischemic ulcers in subjects with critical limb ischaemia Rutherford Category 5 and diabetes mellitus.Critical Limb Ischemia in patients with Diabetes MellitusMedDRA version: 20.0Level: LLTClassification code 10077142Term: Limb ischemiaSystem Organ Class: 100000004866MedDRA version: 20.0Level: LLTClassification code 10058069Term: Critical limb ischemiaSystem Organ Class: 100000004866MedDRA version: 20.0Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2016-003980-21-DERexgenero Limited60